{"schema":"rootz.ai/filing-signals/v1","query":{"ticker":"CLB","limit":50},"count":50,"signals":[{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":100,"match_count":30,"context":"approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis (CD&A), and the compensation of the Companys named executive officers as disclosed pursuant to the United States Securities and Exchange Commissions compensation disclosure rules, including the compensation tables; and 4. To transact such other business as may properl","filed_date":"2026-03-31","accession":"0001193125-26-134986","full_text":"https://origin.rootz.global/static/filing/0001193125-26-134986.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":100,"match_count":77,"context":"ted that significantly increase our compliance costs, pollution mitigation costs, or the cost of any remediation of environmental contamination that may become necessary, and these costs could have a material adverse effect on our business, financial condition, results of operation, or cash flows. Historically, our environmental compliance costs have not had a material adverse effect on our results of operations; howev","filed_date":"2026-03-23","accession":"0001193125-26-118177","full_text":"https://origin.rootz.global/static/filing/0001193125-26-118177.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":100,"match_count":30,"context":"approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis (CD&A), and the compensation of the Companys named executive officers as disclosed pursuant to the United States Securities and Exchange Commissions compensation disclosure rules, including the compensation tables; and 4. To transact such other business as may properl","filed_date":"2025-03-31","accession":"0000950170-25-047865","full_text":"https://origin.rootz.global/static/filing/0000950170-25-047865.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":100,"match_count":79,"context":"ted that significantly increase our compliance costs, pollution mitigation costs, or the cost of any remediation of environmental contamination that may become necessary, and these costs could have a material adverse effect on our business, financial condition, results of operation, or cash flows. Historically, our environmental compliance costs have not had a material adverse effect on our results of operations; howev","filed_date":"2025-02-13","accession":"0000950170-25-019072","full_text":"https://origin.rootz.global/static/filing/0000950170-25-019072.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":100,"match_count":34,"context":"approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis (CD&A), and the compensation of the Companys named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commissions compensation disclosure rules, including the compensation tables; 4. To approve and resolve the amendment and restatement of th","filed_date":"2024-03-19","accession":"0000950170-24-033021","full_text":"https://origin.rootz.global/static/filing/0000950170-24-033021.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":100,"match_count":70,"context":"ted that significantly increase our compliance costs, pollution mitigation costs, or the cost of any remediation of environmental contamination that may become necessary, and these costs could have a material adverse effect on our business, financial condition, results of operation, or cash flows. Historically, our environmental compliance costs have not had a material adverse effect on our results of operations; howev","filed_date":"2024-02-15","accession":"0000950170-24-015483","full_text":"https://origin.rootz.global/static/filing/0000950170-24-015483.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":100,"match_count":25,"context":"ication is required by law, other than those jurisdictions as to which the failure to be so qualified or in good standing could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Each Obligor has the corporate power and authority to own or hold under lease the properties it purports to own or hold under lease, to transact the business it transacts and proposes to transact, t","filed_date":"2023-05-05","accession":"0000950170-23-018053","full_text":"https://origin.rootz.global/static/filing/0000950170-23-018053.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":49,"match_count":3,"context":"00 employees. On May 1, 2023, Core Laboratories N.V. completed its previously announced redomestication transaction (the Redomestication Transaction), which through a series of steps, resulted in the merger of Core Laboratories N.V., a holding company in the Netherlands, with and into Core Laboratories Luxembourg S.A., a public limited liability company incorporated under the laws of Luxembourg, with Core","filed_date":"2026-03-23","accession":"0001193125-26-118177","full_text":"https://origin.rootz.global/static/filing/0001193125-26-118177.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":47,"match_count":4,"context":"ed to date, is filed as Exhibit 19.1 to this Annual Report. ITEM 11. EXECUTIVE COMPENSATION The information set forth under the captions Compensation Discussion and Analysis and Information About our Named Executive Officers and Executive Compensation in Core Labs 2025 Proxy Statement is incorporated herein by reference. ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATT","filed_date":"2025-02-13","accession":"0000950170-25-019072","full_text":"https://origin.rootz.global/static/filing/0000950170-25-019072.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":40,"match_count":5,"context":"not become a party to (I) any agreement, arrangement or understanding (whether written or oral) with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director of the Corporation, shall act or vote in such capacity on any issue or question (a “Voting Commitment”) that has not been disclosed to the Corporation, or (II) any Voting Commitment tha","filed_date":"2026-03-05","accession":"0001193125-26-093962","full_text":"https://origin.rootz.global/static/filing/0001193125-26-093962.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"backlog_growth","strength":32,"match_count":4,"context":"024, for our reservoir core and reservoir fluids analysis services on projects from across the globe that are often conducted in our advanced technology center located in Houston, Texas, as well as a growing demand for CCS projects. Well completion diagnostic services in the U.S. market also showed strong growth in 2024 compared to 2023 although some well diagnostic projects in the Gulf of Mexico were delayed d","filed_date":"2025-02-13","accession":"0000950170-25-019072","full_text":"https://origin.rootz.global/static/filing/0000950170-25-019072.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"margin_pressure","strength":32,"match_count":4,"context":"due to the incremental revenue of $25.7 million in 2023 and the improved utilization of our global laboratory network. Operating income in 2022 was $22.9 million, a decrease of 21% compared to 2021. Operating margins decreased to 7.4% in 2022 compared to 9.2% in 2021. The decrease in operating income and operating margin in 2022, correlates to the decrease in revenue and the decrease in operating margins reflect the increa","filed_date":"2024-02-15","accession":"0000950170-24-015483","full_text":"https://origin.rootz.global/static/filing/0000950170-24-015483.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":31,"match_count":2,"context":"may be time-consuming and expensive for us to alter our business operations to adapt to or comply with any changes in international trade policies and agreements and any failure to do so could have a material adverse effect on our business. Any potential impact will depend on future developments with respect to trade policy and the results of trade negotiations, all of which are beyond our control. These potential impac","filed_date":"2025-10-23","accession":"0001193125-25-248736","full_text":"https://origin.rootz.global/static/filing/0001193125-25-248736.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":31,"match_count":2,"context":"may be time-consuming and expensive for us to alter our business operations to adapt to or comply with any changes in international trade policies and agreements and any failure to do so could have a material adverse effect on our business. Any potential impact will depend on future developments with respect to trade policy and the results of trade negotiations, all of which are beyond our control. These potential impac","filed_date":"2025-07-25","accession":"0000950170-25-098473","full_text":"https://origin.rootz.global/static/filing/0000950170-25-098473.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":31,"match_count":2,"context":"may be time-consuming and expensive for us to alter our business operations to adapt to or comply with any changes in international trade policies and agreements and any failure to do so could have a material adverse effect on our business. Any potential impact will depend on future developments with respect to trade policy and the results of trade negotiations, all of which are beyond our control. These potential impac","filed_date":"2025-04-28","accession":"0000950170-25-058900","full_text":"https://origin.rootz.global/static/filing/0000950170-25-058900.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":29,"match_count":3,"context":"se for the three months ended June 30, 2024, increased by $0.9 million associated with implementation costs of a global human capital management system and a third-party assessment of the Companys IT cybersecurity environment. G&A expense for the three months ended June 30, 2024, of $10.3 million decreased $1.5 million when compared to the $11.8 million for the three months ended March 31, 2023. The s","filed_date":"2024-07-25","accession":"0000950170-24-086610","full_text":"https://origin.rootz.global/static/filing/0000950170-24-086610.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":24,"match_count":3,"context":"ough insurance associated with the fire incident at the Aberdeen, U.K. facility. Cash used in investing activities for the year ended December 31, 2024 of $6.4 million was driven primarily by funding capital expenditures of $13.0 million offset by: 1) $1.7 million of proceeds from sale of assets; 2) $2.1 million of proceeds recovered through insurance associated with the fire incident as previously discussed.; and 3) $2.8 million rec","filed_date":"2026-03-23","accession":"0001193125-26-118177","full_text":"https://origin.rootz.global/static/filing/0001193125-26-118177.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":24,"match_count":3,"context":"he compensation philosophy, policies and procedures described in the section of the Companys proxy statement entitled Compensation Discussion and Analysis (CD&A), and the compensation of the Companys named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commissions compensation disclosure rules, including the compensation tables. Given that more than 50% of the issued share capital was prese","filed_date":"2025-05-27","accession":"0000950170-25-077738","full_text":"https://origin.rootz.global/static/filing/0000950170-25-077738.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":24,"match_count":3,"context":"ere primarily driven by proceeds on the sale of assets of $1.2 million and proceeds from insurance recovery associated with the fire incident at the Aberdeen, U.K. facility of $3.1 million, offset by capital expenditures of $3.6 million, which includes $0.8 million related to the replacement of assets damaged in the fire incident. Cash flows used in investing activities for the three months ended March 31, 2024 of $1.7 million were","filed_date":"2025-04-28","accession":"0000950170-25-058900","full_text":"https://origin.rootz.global/static/filing/0000950170-25-058900.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":24,"match_count":3,"context":"ns of $5.0 million in 2023 compared to non-cash losses of $5.1 million in 2022. Cash used in investing activities for the year ended December 31, 2024 of $6.4 million was driven primarily by funding capital expenditures of $13.0 million offset by: 1) $1.7 million of proceeds from sale of assets, 2) $2.1 million of insurance recovery proceeds on property, plant and equipment associated with the fire incident in one of our facilities","filed_date":"2025-02-13","accession":"0000950170-25-019072","full_text":"https://origin.rootz.global/static/filing/0000950170-25-019072.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":24,"match_count":3,"context":"creased in 2022 by $5.0 million and we were building higher levels of inventory. Cash used in investing activities for the year ended December 31, 2023 of $6.7 million was driven primarily by funding capital expenditures of $10.6 million offset by $3.4 million of net proceeds received on company owned life insurance policies and $0.5 million of proceeds from sales of assets. Cash used by investing activities for the year ended Decemb","filed_date":"2024-02-15","accession":"0000950170-24-015483","full_text":"https://origin.rootz.global/static/filing/0000950170-24-015483.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":24,"match_count":3,"context":"| | | 40,549,322 | | 910,252 | | 62,515 | | — | | Proposal 3a – Approving the Compensation of the Company’s Executive Officers: The compensation of the Company’s named executive officers was approved, on an advisory basis, as follows: | | | | | | | | | | | | | | | | | | | For | | Against | | Abstentions | | Broker Non-Votes | | | | | | | | | | | | 36","filed_date":"2023-07-03","accession":"0000950170-23-031189","full_text":"https://origin.rootz.global/static/filing/0000950170-23-031189.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":23,"match_count":1,"context":"relab.com/sustainability/governance/our-ethics-program.pdf. ITEM 11. EXECUTIVE COMPENSATION The information set forth under the captions Compensation Discussion and Analysis and Information About our Named Executive Officers and Executive Compensation in Core Labs 2024 Proxy Statement is incorporated herein by reference. ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATT","filed_date":"2024-02-15","accession":"0000950170-24-015483","full_text":"https://origin.rootz.global/static/filing/0000950170-24-015483.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":21,"match_count":2,"context":"awards vesting in 2024. The decrease in this compensation cost was partially offset by implementation costs of a global human capital management system and a third-party assessment of the Companys IT cybersecurity environment initiated in 2024. G&A expense for the three months ended September 30, 2024, of $8.6 million decreased $1.6 million compared to the three months ended June 30, 2024. The sequenti","filed_date":"2024-10-24","accession":"0000950170-24-117122","full_text":"https://origin.rootz.global/static/filing/0000950170-24-117122.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"ai_adoption","strength":16,"match_count":2,"context":"rm 10-K. (3) Each of our currently serving non-executive Directors received 8,069 shares of restricted stock, which were granted in 2025 and remain outstanding as of December 31, 2025 subject to fulfillment of vesting conditions. Retainer/Fees Each non-executive Director was paid the following amounts during fiscal year 2025: a base annual retainer, payable semiannually in arrears, in the amount of","filed_date":"2026-03-31","accession":"0001193125-26-134986","full_text":"https://origin.rootz.global/static/filing/0001193125-26-134986.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":16,"match_count":2,"context":"ronically with the SEC. | | | Risk Assessment of Compensation Policies and Practices | | We have assessed our compensation policies and practices and found they are not reasonably likely to have a material adverse effect on us. Our Compensation Committee and our Board are aware of the need to routinely assess our compensation policies and practices and will make a determination as to the necessity of this particular","filed_date":"2026-03-31","accession":"0001193125-26-134986","full_text":"https://origin.rootz.global/static/filing/0001193125-26-134986.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"ai_adoption","strength":16,"match_count":2,"context":"ription operating segment. The total purchase price is comprised of an initial cash payment of $2.3 million plus up to $3.7 million of additional contingent cash consideration, payable in annual installments, provided certain performance targets are achieved over the two-year period following closing. We have not finalized the assessment of the fair values of assets acquired, including intangible ass","filed_date":"2026-03-23","accession":"0001193125-26-118177","full_text":"https://origin.rootz.global/static/filing/0001193125-26-118177.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"backlog_growth","strength":16,"match_count":2,"context":"increased demand for reservoir core and reservoir fluids analysis services on international projects that are often conducted in our advanced technology center located in Houston, Texas, as well as a growing demand for CCS projects. Well completion diagnostic services in the U.S. market also showed strong growth in 2024 compared to 2023. Product Sales Revenue Product sales revenue is equally tied to the comple","filed_date":"2026-03-23","accession":"0001193125-26-118177","full_text":"https://origin.rootz.global/static/filing/0001193125-26-118177.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"margin_pressure","strength":16,"match_count":2,"context":"n loss on the sale of a building, and 3) severance and other charges of $0.5 million. Operating income for the year ended December 31, 2024 was $6.6 million, a decrease of 47% when compared to 2023. Operating margins decreased to 4% in 2024 from 7% in 2023. The decrease in operating income and operating margin in 2024, was primarily due to inventory and other related asset write-downs, loss on the sale of a building, and s","filed_date":"2026-03-23","accession":"0001193125-26-118177","full_text":"https://origin.rootz.global/static/filing/0001193125-26-118177.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":16,"match_count":2,"context":"ceeds from insurance recovery associated with the fire incident at the Aberdeen, U.K. facility of $10.0 million, and proceeds on company owned life insurance policies of $0.8 million, offset by total capital expenditures of $10.9 million and a business acquisition, net of cash acquired of $0.6 million. Cash flows used in investing activities for the nine months ended September 30, 2024 of $2.8 million include the funding of $8.6 mill","filed_date":"2025-10-23","accession":"0001193125-25-248736","full_text":"https://origin.rootz.global/static/filing/0001193125-25-248736.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"ai_adoption","strength":16,"match_count":2,"context":"ription operating segment. The total purchase price is comprised of an initial cash payment of $2.3 million plus up to $3.7 million of additional contingent cash consideration, payable in annual installments, provided certain performance targets are achieved over the two-year period following closing. We have not finalized the assessment of the fair values of assets acquired, including intangible ass","filed_date":"2025-10-23","accession":"0001193125-25-248736","full_text":"https://origin.rootz.global/static/filing/0001193125-25-248736.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"backlog_growth","strength":16,"match_count":2,"context":"atigraphic data. Combined, these datasets and interpretations will help operators derisk their deepwater exploration efforts. Industry engagement in these regional studies has been strong, reflecting growing demand for the Company’s expertise in frontier and deepwater settings. Core Lab is currently formulating additional study proposals across Africa’s offshore Atlantic margin. Complementing thes","filed_date":"2025-10-22","accession":"0001193125-25-246793","full_text":"https://origin.rootz.global/static/filing/0001193125-25-246793.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":16,"match_count":2,"context":"roceeds from insurance recovery associated with the fire incident at the Aberdeen, U.K. facility of $4.7 million and proceeds on company owned life insurance policies of $0.8 million, offset by total capital expenditures of $7.9 million, which includes $1.6 million related to the replacement of assets and the facility which were damaged in the 2024 fire 33 [Return to Index](#index) incident, and a business acquisition, net of cash","filed_date":"2025-07-25","accession":"0000950170-25-098473","full_text":"https://origin.rootz.global/static/filing/0000950170-25-098473.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":16,"match_count":2,"context":"ronically with the SEC. | | | Risk Assessment of Compensation Policies and Practices | | We have assessed our compensation policies and practices and found they are not reasonably likely to have a material adverse effect on us. Our Compensation Committee and our Board are aware of the need to routinely assess our compensation policies and practices and will make a determination as to the necessity of this particular","filed_date":"2025-03-31","accession":"0000950170-25-047865","full_text":"https://origin.rootz.global/static/filing/0000950170-25-047865.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":16,"match_count":2,"context":"t of onshore and offshore crude oil fields will be required to meet demand. In the near term, the Company expects that crude oil markets will remain volatile due to global economic uncertainties and geopolitical risks. In January of 2025, expanded sanctions 1) impacted the maritime movement and trading of crude oil and derived products, along with the demand for necessary laboratory assay work, and 2) prohibited","filed_date":"2025-01-29","accession":"0000950170-25-010552","full_text":"https://origin.rootz.global/static/filing/0000950170-25-010552.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":16,"match_count":2,"context":"el of inventory during the nine months ended September 30, 2024. Cash flows used in investing activities for the nine months ended September 30, 2024 of $2.8 million were primarily driven by funding capital expenditures of $8.6 million offset by proceeds on the sale of assets of $0.9 million, net proceeds of $2.1 million from insurance recovery associated with the fire incident earlier in the year at one of the U.K. facilities and","filed_date":"2024-10-24","accession":"0000950170-24-117122","full_text":"https://origin.rootz.global/static/filing/0000950170-24-117122.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":16,"match_count":2,"context":"Consolidation On May 1, 2023, Core Laboratories N.V. completed its previously announced redomestication transaction (the Redomestication Transaction) which through a series of steps, resulted in the merger of Core Laboratories N.V., a holding company in the Netherlands, with and into Core Laboratories Luxembourg S.A., a public limited liability company incorporated under the laws of Luxembourg, with Core","filed_date":"2024-10-24","accession":"0000950170-24-117122","full_text":"https://origin.rootz.global/static/filing/0000950170-24-117122.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":16,"match_count":2,"context":"entory and accounts payable during the six months ended June 30, 2024. Cash flows used in investing activities for the six months ended June 30, 2024 of $2.3 million were driven primarily by funding capital expenditures of $5.9 million offset by proceeds on the sale of assets of $0.8 million and proceeds on company owned life insurance policies of $2.8 million. Cash flows used in investing activities for the six months ended June 3","filed_date":"2024-07-25","accession":"0000950170-24-086610","full_text":"https://origin.rootz.global/static/filing/0000950170-24-086610.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":16,"match_count":2,"context":"Consolidation On May 1, 2023, Core Laboratories N.V. completed its previously announced redomestication transaction (the Redomestication Transaction) which through a series of steps, resulted in the merger of Core Laboratories N.V., a holding company in the Netherlands, with and into Core Laboratories Luxembourg S.A., a public limited liability company incorporated under the laws of Luxembourg, with Core","filed_date":"2024-07-25","accession":"0000950170-24-086610","full_text":"https://origin.rootz.global/static/filing/0000950170-24-086610.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":16,"match_count":2,"context":"he compensation philosophy, policies and procedures described in the section of the Companys proxy statement entitled Compensation Discussion and Analysis (CD&A), and the compensation of the Companys named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commissions compensation disclosure rules, including the compensation tables; and (4) to approve and resolve the amendment and restatement o","filed_date":"2024-05-10","accession":"0000950170-24-057934","full_text":"https://origin.rootz.global/static/filing/0000950170-24-057934.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":16,"match_count":2,"context":"y improved its levels of working capital associated with inventory. Cash flows used in investing activities for the three months ended March 31, 2024 of $1.7 million were driven primarily by funding capital expenditures of $3.1 million offset by proceeds on the sale of assets of $0.6 million and proceeds on company owned life insurance policies of $0.8 million. Cash flows used in investing activities for the three months ended Marc","filed_date":"2024-04-25","accession":"0000950170-24-048414","full_text":"https://origin.rootz.global/static/filing/0000950170-24-048414.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":16,"match_count":2,"context":"Consolidation On May 1, 2023, Core Laboratories N.V. completed its previously announced redomestication transaction (the Redomestication Transaction) which through a series of steps, resulted in the merger of Core Laboratories N.V., a holding company in the Netherlands, with and into Core Laboratories Luxembourg S.A., a public limited liability company incorporated under the laws of Luxembourg, with Core","filed_date":"2024-04-25","accession":"0000950170-24-048414","full_text":"https://origin.rootz.global/static/filing/0000950170-24-048414.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"ai_adoption","strength":16,"match_count":2,"context":"Mr. Bruno is the only NEO that has reached the age 62 vesting requirement. The Severance Payment or the Change in Control Payment, as applicable, will generally be paid to the executive in equal installments over a twelve-month period following the applicable termination of employment, although certain payments may be made at different times in order to comply with Section 409A of the Code. The 2024","filed_date":"2024-03-19","accession":"0000950170-24-033021","full_text":"https://origin.rootz.global/static/filing/0000950170-24-033021.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"risk_factor","strength":16,"match_count":2,"context":"essment of Compensation Policies and Practices | | We have assessed our compensation policies and practices and found that the compensation policies and practices are not reasonably likely to have a material adverse effect on us. Our Compensation Committee and our Board are aware of the need to routinely assess our compensation policies and practices and will make a determination as to the necessity of this particular","filed_date":"2024-03-19","accession":"0000950170-24-033021","full_text":"https://origin.rootz.global/static/filing/0000950170-24-033021.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"backlog_growth","strength":16,"match_count":2,"context":"vity for our reservoir core and reservoir fluids analysis services on projects from across the globe that are often conducted in our advanced technology center located in Houston, Texas, as well as a growing demand for CCS projects. Service revenue for the year ended December 31, 2022, was $347.0 million, relatively flat compared to 2021. Disruptions resulting from the COVID-19 pandemic started to ease, and dem","filed_date":"2024-02-15","accession":"0000950170-24-015483","full_text":"https://origin.rootz.global/static/filing/0000950170-24-015483.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":16,"match_count":2,"context":"f the products we sell as supply chains continue to be disrupted. Cash flows used in investing activities for the nine months ended September 30, 2023 of $4.2 million were driven primarily by funding capital expenditures of $7.8 million offset by net proceeds received on company owned life insurance policies of $3.4 million. Cash flows used in investing activities for the nine months ended September 30, 2022 of $4.9 million were dri","filed_date":"2023-11-02","accession":"0000950170-23-058206","full_text":"https://origin.rootz.global/static/filing/0000950170-23-058206.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":16,"match_count":2,"context":"ntinue to be much longer than average lead times prior to the pandemic. Cash flows used in investing activities for the six months ended June 30, 2023 of $0.8 million were driven primarily by funding capital expenditures of $4.4 million offset by net proceeds received on company owned life insurance policies of $3.4 million. Cash flows used in investing activities for the six months ended June 30, 2022 of $2.4 million were driven pr","filed_date":"2023-07-27","accession":"0000950170-23-035213","full_text":"https://origin.rootz.global/static/filing/0000950170-23-035213.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"ai_adoption","strength":16,"match_count":2,"context":"chaser’s satisfaction. Section 4. Conditions to Closing. Each Purchaser’s obligation to purchase and pay for the Notes to be sold to such Purchaser at the Closing is subject to the fulfillment to such Purchaser’s satisfaction, prior to or at the Closing, of the following conditions: Section 4.1. Representations and Warranties. (a) Representations and Warranties of the Obligors.","filed_date":"2023-05-05","accession":"0000950170-23-018053","full_text":"https://origin.rootz.global/static/filing/0000950170-23-018053.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"strategic_event","strength":16,"match_count":2,"context":"iary of either Obligor, or (y) convey, transfer or lease all of its assets in compliance with the provisions of Section 10.3; and (2) the foregoing restriction does not apply to the consolidation or merger of any Obligor with, or the conveyance, transfer or lease of substantially all of the assets of any Obligor in a single transaction or series of transactions to, any Person so long as: (a) the successor","filed_date":"2023-05-05","accession":"0000950170-23-018053","full_text":"https://origin.rootz.global/static/filing/0000950170-23-018053.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CLB","company":"Core Laboratories Inc. /DE/","exchange":"NYSE","sector":"Oil & Gas Field Services, NEC","signal_type":"capex_increase","strength":16,"match_count":2,"context":"also Credit Facility, Senior Notes and Available Future Liquidity below regarding a net increase in our debt of $3.4 million. Uses of cash during the six months ended June 30, 2026 include: 1) total capital expenditures of $10.7 million, which includes $2.5 million related to the rebuilding of the facility and replacement of assets damaged in the Aberdeen, U.K. fire incident which have been covered by insurance proceeds received in","filed_date":"2026-07-30","accession":"0001193125-26-326345","full_text":"https://origin.rootz.global/static/filing/0001193125-26-326345.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."}],"origin":{"leaf":"7ff3167b6e4ac66b69b3e22cd028d654cfb9ae7759ad7da4fee6f342eda8ab30","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"e93d6d8a40c27e8a928d493de9acbfa747e902d7c141b6fef0438ac98ea631f1","parent":null,"source":"signal_search","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256() || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":100,"hourly_limit":500,"remaining":400,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}